Gain-of-function germline heterozygous RET mutations cause multiple endocrine neoplasia type 2 (MEN 2), characterized by medullary thyroid carcinoma and pheochromocytoma. This evidence concerns the gene RET and multiple endocrine neoplasia type 2.